Microchemical Journal, Journal Year: 2024, Volume and Issue: unknown, P. 112589 - 112589
Published: Dec. 1, 2024
Language: Английский
Microchemical Journal, Journal Year: 2024, Volume and Issue: unknown, P. 112589 - 112589
Published: Dec. 1, 2024
Language: Английский
Materials Science and Engineering B, Journal Year: 2025, Volume and Issue: 314, P. 118057 - 118057
Published: Feb. 6, 2025
Language: Английский
Citations
1Bioelectrochemistry, Journal Year: 2024, Volume and Issue: 161, P. 108847 - 108847
Published: Nov. 15, 2024
Language: Английский
Citations
4ACS Synthetic Biology, Journal Year: 2025, Volume and Issue: 14(1), P. 21 - 40
Published: Jan. 6, 2025
The field of healthcare diagnostics is navigating complex challenges driven by evolving patient demographics and the rapid advancement new technologies worldwide. In response to these challenges, biosensors offer distinctive advantages over traditional diagnostic methods, such as cost-effectiveness, enhanced specificity, adaptability, making their integration with point-of-care (POC) platforms more feasible. recent years, aptasensors have significantly evolved in capabilities through emerging microfluidics, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) systems, wearable devices, machine learning (ML), driving progress precision medicine global solutions. Moreover, advancements not only improve accuracy but also hold potential revolutionize early detection, reduce costs, outcomes, especially resource-limited settings. This Account examines key advancements, focusing on how scientific breakthroughs, including artificial intelligence (AI), improved sensitivity precision. Additionally, has enabled real-time monitoring data analysis, fostering advances personalized healthcare. Furthermore, commercialization aptasensor could increase availability clinical settings support use widespread solutions for health challenges. Hence, this review discusses technological improvements, practical uses, prospects while surrounding standardization, validation, interdisciplinary collaboration application. Finally, ongoing efforts address are ensure that can be effectively implemented diverse systems.
Language: Английский
Citations
0Materials Science and Engineering B, Journal Year: 2025, Volume and Issue: 314, P. 118073 - 118073
Published: Feb. 3, 2025
Language: Английский
Citations
0Biosensors, Journal Year: 2025, Volume and Issue: 15(2), P. 80 - 80
Published: Jan. 31, 2025
Detecting multiple tumor markers is of great importance. It helps in early cancer detection, accurate diagnosis, and monitoring treatment. In this work, gold nanoparticles–toluidine blue–graphene oxide (AuNPs-TB–GO) nanoparticles–carboxyl ferrocene–tungsten disulfide (AuNPs–FMC–WS2) nanocomposites were prepared for labeling Carcinoembryonic antigen (CEA) antibody Carbohydrate 72–4 (CA72-4) antibody, respectively, used as two kinds probes with different electrochemical signals. With the excellent magnetic performance biotin immune beads (IMBs), biofunctional IMBs firmly deposited on glassy carbon electrode (MGCE) surface by applying a constant field, then CEA CA72-4 immobilized avidin–biotin conjugation. The assay was based change detection peak current. Under optimum experimental conditions, linear range two-component immunosensor from 0.01 to 120 ng/mL, low limit 0.003 0.05 35 U/mL, 0.016 U/mL. results showed that proposed enabled simultaneous exhibited good reproducibility, high selectivity, sensitivity. particular, multiplexed immunoassay approach does not require sophisticated fabrication well-suited high-throughput biosensing application other areas.
Language: Английский
Citations
0Surfaces and Interfaces, Journal Year: 2025, Volume and Issue: unknown, P. 106047 - 106047
Published: Feb. 1, 2025
Language: Английский
Citations
0Materials, Journal Year: 2025, Volume and Issue: 18(5), P. 1014 - 1014
Published: Feb. 25, 2025
A hydrothermal and combustion-reduction process with polyvinyl pyrrolidone (PVP) as a restricted growth agent galactose reducing was developed for the fabrication of rod-like α-Fe2O3/Fe3O4 magnetic nanocomposites (MNCs). Firstly, β-FeOOH nanorods (NRs) were fabricated by method, PVP agent. To obtain smaller size better applications in biomedical field, concentrations FeCl3 PVP, temperature, time optimized 0.171 M, 0.163 mM, 100 °C, 8 h, NRs 193.1 nm average length 43.2 diameter. Then, precursors, MNCs prepared via agent; factors calcination temperature mass ratio assessed 300 0.5 1:2, respectively. The under conditions 81.6 23.9 diameter, while their saturation magnetization reached 69.8 emu/g.
Language: Английский
Citations
0Ceramics International, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 1, 2024
Language: Английский
Citations
3Colloids and Surfaces B Biointerfaces, Journal Year: 2024, Volume and Issue: 239, P. 113963 - 113963
Published: May 13, 2024
Language: Английский
Citations
2Microchemical Journal, Journal Year: 2024, Volume and Issue: unknown, P. 112589 - 112589
Published: Dec. 1, 2024
Language: Английский
Citations
0